Constellation illuminates rare disease genetics
Cheng, S.; Zhang, Q.; Zheng, X.; Jhangiani, S. N.; Weir, J. C.; Farek, J. R.; Mehta, H. H.; Khan, Z. M.; Han, Y.; Dinh, H. H.; Blankenburg, K. R.; Posey, J. E.; Gibbs, R. A.; Muzny, D. M.; Carvalho, C. M. B.; Bekritsky, M. A.; Crawford, A.; Calame, D. G.; Han, J.; Sedlazeck, F. J.
Show abstract
Despite significant advances in genomic sequencing, the resolution of many rare disease cases is still hindered by variant detection limitations. Short reads struggle in homologous regions, and long reads remain costly and difficult to scale. Here, we present the first systematic evaluation of Illuminas Constellation sequencing technology for rare disease research. By fragmenting long DNA molecules directly on the flow cell surface, Constellation unlocks proximity information that enables long-range phasing and structural variant detection. Across 21 families, Constellation independently identified all known causative variants and resolved previously unsolved trios. It reliably resolved complex structural and copy number variants (e.g. impacting MECP2) and recovered haplotype phasing information across key disease impacting variants, all from low DNA input using existing Illumina infrastructure. These findings establish Constellation as a scalable, cost-efficient advance, closing critical diagnostic gaps and broadening access to long-range variant analysis in rare disease genomics.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection 97%
- Impact of genome build on RNA-seq interpretation and diagnostics 97%
- Detecting cryptic clinically-relevant structural variation in exome sequencing data increases diagnostic yield for developmental disorders 96%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project. 96%
- Genome-wide prediction of pathogenic gain- and loss-of-function variants from ensemble learning of diverse feature set 96%
- Multi-modal investigation of the schizophrenia-associated 3q29 genomic interval reveals global genetic diversity with unique haplotypes and segments that increase the risk for non-allelic homologous recombination 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.